`
`Filed on behalf of: Philip Morris Products, S.A.
`
`
`
`
`
`Entered: September 18, 2020
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`_______________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`_______________________
`
`
`
`
`
`
`
`PHILIP MORRIS PRODUCTS, S.A.,
`Petitioner,
`
`v.
`
`RAI STRATEGIC HOLDINGS, Inc.,
`Patent Owner.
`_______________________
`Case IPR2020-00919
`Patent 9,901,123
`______________________
`
`
`PETITIONER’S REPLY TO THE
`PATENT OWNER PRELIMINARY RESPONSE
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`IPR2020-00919 (USP 9,901,123)
`
`
`
`Petitioner’s Reply to POPR
`
`TABLE OF AUTHORITIES
`
`CASES
`
` Page(s)
`
`3Shape A/S v. Align Tech.,
`IPR2020-00223, Paper 12 (May 26, 2020) ........................................................... 3
`
`Advanced Bionics, LLC v. Med-El Elektromedizinische Gerate
`GMBH,
`IPR2019-01469, Paper 6 (Feb. 13, 2020) ............................................................. 1
`Amazon.com v. M2M Sols.,
`IPR2019-01204, Paper 14 (Jan. 23, 2020) ............................................................ 2
`Apple Inc. v. Fintiv, Inc.,
`IPR2020-00019, Paper 11 (Mar. 20, 2020) .............................................. 2, 4, 5, 7
`Apple Inc. v. Fintiv, Inc.,
`IPR2020-00019, Paper 15 (May 13, 2020) ........................................................... 4
`Apple Inc. v. Maxell, Ltd.,
`IPR2020-00202, Paper 11 (July 15, 2020) ....................................................... 4, 5
`Apple Inc. v. Seven Networks,
`IPR2020-00506, Paper 11 (Sept. 1, 2020) ............................................................ 7
`Bio-Rad Labs. v. 10x Genomics,
`IPR2019-00567, Paper 23 (Aug. 8, 2019) ............................................................ 3
`Comcast Cable Commc’ns v. Veveo,
`IPR2019-00239, Paper 15 (July 5, 2019) ............................................................. 5
`Emerson Elec. Co. v. SIPCO,
`IPR2019-00547, Paper 15 (Aug. 30, 2019) .......................................................... 3
`Juniper Networks v. Packet Intelligence,
`IPR2020-00338, Paper 22 (Sept. 9, 2020) ............................................................ 7
`Nichia Corp. v. Lighting Sci. Group Corp.,
`IPR2019-01259, Paper 21 (Jan. 15, 2020) ............................................................ 3
`
`i
`
`
`
`IPR2020-00919 (USP 9,901,123)
`
`
`
`Petitioner’s Reply to POPR
`
`Samsung Elecs. Co. v. Dynamics,
`IPR2020-00499, Paper 41 (Aug. 12, 2020) .................................................. 3, 4, 6
`Volkswagen Grp. of Am. v. Mich. Motor Techs,
`IPR2020-00452, Paper 12 (Sept. 9, 2020) ............................................................ 2
`Yeda Research v. Mylan Pharms.,
`906 F.3d 1031 (Fed. Cir. 2018) ........................................................................ 5, 6
`Zonar Sys. v. Innovative Global Sys.,
`IPR2020-00154, Paper 16 (May 12, 2020) ........................................................... 5
`STATUTES
`28 U.S.C. § 1659 ........................................................................................................ 7
`
`
`ii
`
`
`
`IPR2020-00919 (USP 9,901,123)
`
`
`
`Petitioner’s Reply to POPR
`
`Exhibit List
`
`Ex.
`Description
`1001 U.S. Patent No. 9,901,123 (“the ’123 patent”)
`1002
`File History for U.S. Patent No. 9,901,123
`1003 Declaration of Dr. Seetharama C. Deevi in Support of Petition for
`Inter Partes Review of ’123 Patent (“Deevi Decl”)
`1004 Curriculum Vitae of Dr. Seetharama C. Deevi
`1005 U.S. Patent No. 5,249,586 (“Morgan”)
`1006 U.S. Patent No. 4,947,874 (“Brooks”)
`1007 U.S. Patent Application Publication No. 2007/0102013 (“Adams”)
`1008 U.S. Patent No. 5,144,962 (“Counts-962”)
`1009 U.S. Patent No. 5,060,671 (“Counts-671”)
`1010 Chemical and Biological Studies on New Cigarette Prototypes that
`Heat Instead of Burn Tobacco, R. J. Reynolds Tobacco Company
`Monograph (1988) (“RJR’s 1988 Monograph”) (markings on exhibit
`appeared in the used copy purchased by counsel)
`1011 U.S. Patent No. 5,692,525 (“Counts-525”)
`1012 U.S. Patent No. 5,095,921 (“Losee”)
`1013 U.S. Patent No. 5,591,368 (“the ’368 patent”)
`1014
`International Patent Application Publication No. WO 96/32854
`(“Baggett”)
`1015 Korean Patent No. 10-0636287 (“Park”)
`(including certified English translation and original Korean version of
`patent)
`Philip Morris Incorporated Invention Record (submitted May 19,
`1994; witnessed May 23, 1994) (“May 1994 Invention Record”)
`1017 U.S. Patent No. 4,510,950 (“Keritsis”)
`
`1016
`
`iii
`
`
`
`IPR2020-00919 (USP 9,901,123)
`
`
`
`Petitioner’s Reply to POPR
`
`Ex.
`1018
`
`1019
`
`1020
`
`Description
`Steven M. Kaplan, Wiley Electrical and Electronics Engineering
`Dictionary (2004)
`IEEE 100, The Authoritative Dictionary of IEEE Standards Terms (7th
`ed. 2000) (“IEEE Dictionary”)
`Philip Morris Incorporated Invention Record (dated October 11, 1988)
`(“October 1988 Invention Record”)
`1021 U.S. Patent No. 2,104,266 (“McCormick”)
`1022 U.S. Patent No. 5,865,185 (“Collins”)
`1023 U.S. Patent Application Publication No. 2007/0215167 (“Crooks”)
`1024 U.S. Provisional Application Serial No. 60/722,036
`1025
`Patent Owner’s infringement chart for ’123 patent, In the Matter of
`Certain Tobacco Heating Articles and Components Thereof, Inv. No.
`___, EDIS Doc. ID 707369 (Filed Apr. 9, 2020) (“Infringement
`Chart”)
`1026 U.S. Patent No. 5,498,855 (“the ’855 patent”)
`1027 Modern Dictionary of Electronics (7th ed., 1999) (excerpt)
`1028 Merriam-Webster’s Collegiate Dictionary (10th ed., 2001) (excerpt)
`1029 Concise Oxford English Dictionary (11th ed., 2008) (excerpt)
`1030
`The Lady Smokes, www.theladysmokes.com (archived at
`web.archive.org, 2006-2007)
`1031 Chambers Dictionary of Science and Technology (1999) (excerpt)
`1032 Complaint for Patent Infringement, RAI Strategic Holdings, Inc. v.
`Altria Client Services, No. 1:20-cv-393 (E.D. Va. April 9, 2020)
`1033 Document Filing Report for In the Matter of Certain Tobacco Heating
`Articles and Components Thereof, No. 337-TA-1199 (ITC filed April
`9, 2020)
`
`iv
`
`
`
`IPR2020-00919 (USP 9,901,123)
`
`
`
`Petitioner’s Reply to POPR
`
`1036
`
`1037
`
`1038
`
`1040
`
`Ex.
`Description
`1034 Civil docket report for RAI Strategic Holdings, Inc. v. Altria Client
`Services LLC, No. 1:20-cv-00393-LO-TCB (E.D. Va. filed April 9,
`2020)
`1035 Order Granting Defendants’ Unopposed Motion to Invoke the
`Statutory Stay of Plaintiff’s Claims Relating to U.S. Patent Nos.
`9,839,238, 9,901,123, and 9,930,915 Pursuant to 28 U.S.C. §1659, RAI
`Strategic Holdings, Inc. v. Altria Client Services LLC, No. 1:20-cv-
`00393-LO-TCB (E.D. Va. June 19, 2020), ECF No. 27
`Excerpt from Respondent’s Joint Disclosure of Final Contentions from
`ITC Investigation 337-TA-1199 (September 18, 2020) (Final
`Invalidity Contentions)
`Exhibit C1 to Respondent’s Joint Disclosure of Final Contentions from
`ITC Investigation 337-TA-1199 (September 18, 2020) (Final
`Invalidity Contentions)
`Joint Claim Construction Chart, In the Matter of Certain Tobacco
`Heating Articles and Components Thereof, No. 337-TA-1199 (ITC
`August 13, 2020)
`1039 Commission Opinion, In the Matter of Certain Unmanned Aerial
`Vehicles and Components Thereof, No. 337-TA-1133 (ITC September
`8, 2020)
`Philip Morris Products SA’s Comments to Complainants’ Public
`Interest Statement, In the Matter of Certain Tobacco Heating Articles
`and Components Thereof, No. 337-TA-1199 (ITC April 23, 2020)
`1041 Comments of The American Conservative Union, In the Matter of
`Certain Tobacco Heating Articles and Components Thereof, No. 337-
`1199 (ITC April 22, 2020)
`Public Interest Comments of the Consumer Advocates for Smoke-free
`Alternatives Association, In the Matter of Certain Tobacco Heating
`Articles and Components Thereof, No. 337-TA-1199 (ITC April 23,
`2020)
`
`1042
`
`v
`
`
`
`IPR2020-00919 (USP 9,901,123)
`
`
`
`Petitioner’s Reply to POPR
`
`Ex.
`1043
`
`1044
`
`1045
`
`1046
`
`1047
`
`1048
`
`1049
`
`1050
`
`1051
`
`Description
`Public Interest Comments of Congressman George Holding, In the
`Matter of Certain Tobacco Heating Articles and Components Thereof,
`No. 337-TA-1199 (ITC April 15, 2020)
`Public Interest Comments of Dr. Nikan H. Khatibi, MD, In the Matter
`of Certain Tobacco Heating Articles and Components Thereof, No.
`337-TA-1199 (ITC April 23, 2020)
`Public Interest Comments of Nextera Healthcare, In the Matter of
`Certain Tobacco Heating Articles and Components Thereof, No. 337-
`TA-1199 (ITC April 23, 2020)
`Public Interest Comments of the Progressive Policy Institute, In the
`Matter of Certain Tobacco Heating Articles and Components Thereof,
`No. 337-TA-1199 (ITC April 23, 2020)
`Public Interest Comments of the Reason Foundation, In the Matter of
`Certain Tobacco Heating Articles and Components Thereof, No. 337-
`TA-1199 (ITC April 23, 2020)
`Public Interest Comments of the Schizophrenia and Related Disorder
`Alliance of America, In the Matter of Certain Tobacco Heating
`Articles and Components Thereof, No. 337-TA-1199 (ITC April 23,
`2020)
`Public Interest Comments of the Smoke-Free Alternatives Trade
`Association, In the Matter of Certain Tobacco Heating Articles and
`Components Thereof, No. 337-TA-1199 (ITC April 23, 2020)
`Public Interest Comments of Spark MD, In the Matter of Certain
`Tobacco Heating Articles and Components Thereof, No. 337-TA-1199
`(ITC April 23, 2020)
`Public Interest Comments of TechFreedom, In the Matter of Certain
`Tobacco Heating Articles and Components Thereof, No. 337-TA-1199
`(ITC April 23, 2020)
`
`vi
`
`
`
`IPR2020-00919 (USP 9,901,123)
`
`
`
`Petitioner’s Reply to POPR
`
`Ex.
`1052
`
`1053
`
`Description
`FDA News release, FDA Authorizes Marketing of IQOS Tobacco
`Heating System with ‘Reduced Exposure’ Information (July 7, 2020),
`https://www.fda.gov/news-events/press-announcements/fda-
`authorizes-marketing-iqos-tobacco-heating-system-reduced-exposure-
`information
`FDA News release, FDA permits sale of IQOS Tobacco Heating
`System through premarket tobacco product application pathway (April
`30, 2019), https://www.fda.gov/news-events/press-
`announcements/fda-permits-saleiqos-tobacco-heating-system-through-
`premarket-tobacco-product-application-pathway
`
`vii
`
`
`
`IPR2020-00919 (USP 9,901,123)
`
`
`
`Petitioner’s Reply to POPR
`
`I.
`
`Section 325(d) Provides No Basis for a Discretionary Denial
`Analysis under either prong of the Advanced Bionics test reveals that
`discretionary denial is unwarranted. First, the Office was never presented with the
`arguments in the Petition, and Patent Owner buried the relevant art instead of
`presenting it to the Office. Certainly, applicants may present art in an IDS.
`Advanced Bionics, LLC v. Med-El Elektromedizinische Gerate GMBH, IPR2019-
`01469, Paper 6 at 8 (Feb. 13, 2020) (precedential). But here, Patent Owner hid the
`relevant art among over three hundred other references in an IDS (Ex. 1002 at
`148-60) and countless references cited in the patent. Patent Owner also ignored the
`Examiner’s plea to “specifically” identify “any particular reference or portion of a
`reference” in this “extremely large number of references.” Ex. 1002 at 142; Pet. 13
`(quoting). This is not presenting the Office with relevant art, this is hiding it.
`Second, even if burying art constitutes presenting it, the Examiner
`committed multiple errors “material to the patentability of the challenged claims.”
`Advanced Bionics at 8. To start, the Examiner compared the art to the wrong claim
`language when ostensibly finding the challenged claims contained allowable
`subject matter. After reciting claim elements that are not in any of this patent’s
`claims, the Examiner concluded that “the closest prior art” does not teach a clause
`that recites, inter alia, “wick[ing]” a liquid “into contact with the electrical
`resistance heater.” Ex. 1002 at 142-44. That clause is not in the challenged claims.
`Other than comparing the wrong art to the wrong claim language, the record is
`“silent,” and the Examiner therefore erred by “overlooking specific teachings of
`the relevant prior art” with respect to the challenged claims. Advanced Bionics at 8
`
`1
`
`
`
`IPR2020-00919 (USP 9,901,123)
`
`
`
`Petitioner’s Reply to POPR
`
`n.9, 10. For example, the Examiner erred by failing to identify the teachings in
`Morgan, Adams, and Counts-962 regarding heaters positioned proximal to the
`center, and by not comparing those teachings to that claim feature. Amazon.com v.
`M2M Sols., IPR2019-01204, Paper 14 at 16-17 (Jan. 23, 2020). In fact, it is error to
`overlook relevant teachings even if other parts of the same reference were used to
`reject the claims. Volkswagen Grp. of Am. v. Mich. Motor Techs, IPR2020-00452,
`Paper 12 at 32-33 (Sept. 9, 2020). And until now, the Office has never been
`presented with the Petition’s arguments, expert testimony, and other supporting
`evidence showing that, e.g., positioning a heater proximal to the center was known
`and the many advantages of doing so. Accordingly, the Board should decline
`Patent Owner’s request for discretionary denial under § 325(d).
`
`II. Discretionary Denial is Not Warranted under NHK/Fintiv
`A “holistic” evaluation reveals that institution furthers the Board’s
`considerations of “efficiency, fairness, and the merits.” Apple Inc. v. Fintiv, Inc.,
`IPR2020-00019, Paper 11 at 6 (Mar. 20, 2020) (precedential) (“Fintiv”). To begin,
`Petitioner was exceptionally diligent, filing its IPR on May 8, less than one month
`after April 9, when Patent Owner filed its complaints in the ITC and district court
`(“EDVA”), and before Petitioner answered/responded in either case. Exs. 1033,
`1034. In fact, Petitioner filed its IPR even before the ITC instituted its investigation
`on May 11. Ex. 2027. Nothing of substance occurred in the EDVA case before it
`was stayed on June 18, pending the ITC proceeding. Ex. 1035; see also Fintiv at
`11-12 (Petitioner’s diligence favors institution).
`The Board consistently grants institution even when the IPR was filed later
`
`2
`
`
`
`IPR2020-00919 (USP 9,901,123)
`
`
`
`Petitioner’s Reply to POPR
`
`relative to the parallel ITC case because “the ITC does not have the power to
`cancel a patent claim,” 3Shape A/S v. Align Tech., IPR2020-00223, Paper 12, at
`33-34 (May 26, 2020), and “[t]he stay of the [district court] proceeding allays
`concerns about inefficiency and duplication of efforts as it relates to this
`proceeding. Samsung Elecs. Co. v. Dynamics, IPR2020-00499, Paper 41 at 11-16
`(Aug. 12, 2020); Nichia Corp. v. Lighting Sci. Group Corp., IPR2019-01259,
`Paper 21 at 27-28 (Jan. 15, 2020) (instituting despite the “same claims … using the
`same prior art, the same arguments, and the same evidence”); Emerson Elec. Co. v.
`SIPCO, IPR2019-00547, Paper 15 at 9 (Aug. 30, 2019) (“[A]n ITC decision …
`may inform our decision, [but] it does not render our proceeding duplicative or …
`waste the Board’s resources.”). The Office is “the lead agency in assessing the
`patentability, or validity, of proposed or issued claims.” Certain Unmanned Aerial
`Vehicles and Components Thereof, No. 337-TA-1133 (Sept. 8, 2020) (suspending
`enforcement over the Board’s final written decisions) (Ex. 1039 at 37).
`Patent Owner cites only one case where the Board denied institution with a
`co-pending ITC case, Bio-Rad (POPR 61), but that case is inapposite. The Board
`denied institution in Bio-Rad because the petitioner failed to demonstrate a
`reasonable likelihood of prevailing on the merits and delayed filing its IPR so long
`that the ITC had already issued a detailed final Initial Determination rejecting the
`same arguments challenging the same claims with the same art and the same expert
`witnesses. Bio-Rad Labs. v. 10x Genomics, IPR2019-00567, Paper 23 at 26-29
`(Aug. 8, 2019). Unlike Bio-Rad, Petitioner here diligently filed a meritorious
`petition applying different art, and did so just one month into the one-year statutory
`
`3
`
`
`
`IPR2020-00919 (USP 9,901,123)
`
`
`
`Petitioner’s Reply to POPR
`
`period to ensure the Board may institute well before the ITC’s Initial
`Determination scheduled for May 14, 2021. Ex. 2029 at 4.
`As expected given Petitioner’s exceptional diligence, the Fintiv factors
`demonstrate that institution is warranted. First, the EDVA case is stayed (Fintiv
`factor 1). Contrary to Patent Owner’s unsupported attorney argument (POPR 62),
`the district court’s stay weighs strongly against denial even with a parallel ITC
`case. Samsung at 11-12 (“The stay of the [district court] proceeding allays
`concerns about inefficiency and duplication of efforts as it relates to this
`proceeding.”). If relevant at all, whether the ITC will stay the case is neutral
`because the Board will not speculate how a tribunal will rule. Apple Inc. v. Fintiv,
`Inc., IPR2020-00019, Paper 15 at 12 (May 13, 2020) (informative) (“Fintiv II”).
`The lack of overlap between the ITC case and the IPR also favors institution.
`Fintiv at 9 & n.14 (pointing to Fintiv factor 4). Patent Owner alleged perfect
`overlap based on Petitioner’s preliminary infringement contentions. POPR 64.
`Petitioner, however, has chosen to litigate the IPR grounds at the PTAB: its final
`ITC contentions (Exs. 1036, 1037) do not raise the same grounds as the IPR. Apple
`Inc. v. Maxell, Ltd., IPR2020-00202, Paper 11 at 17 (July 15, 2020) (evaluating
`final contentions instead of initial contentions) (“Maxell”). Counts-962 (Ground 3
`primary reference) is not asserted as prior art at all. Adams (Ground 2 primary
`reference) still appears in the ITC as a secondary reference, but only with different
`primary references (the Accord product and Hajaligol). This is a far cry from its
`role as a primary reference, as Patent Owner recognizes. Compare POPR 15-42
`(addressing Morgan in view of Adams) with 42-49 (Adams in view of Morgan);
`
`4
`
`
`
`IPR2020-00919 (USP 9,901,123)
`
`
`
`Petitioner’s Reply to POPR
`
`Maxell at 14-18. The ITC proceeding also lacks the IPR’s Ground 1. While there is
`some overlap—both proceedings include Morgan as a primary reference—the
`proceedings use different secondary references, most notably Adams in the IPR
`and “bullet heater” prior art in the ITC (where its publication date was established
`via third-party subpoena, a procedure unavailable to prospective petitioners). Ex.
`1036 at 92-93; Ex. 1037. The IPR also uses a bullet-heater disclosure as evidence,
`but “supporting evidence” is not “prior art.” Yeda Research v. Mylan Pharms.,
`906 F.3d 1031, 1041-42 (Fed. Cir. 2018).
`In addition to those significant differences, the ITC proceeding will involve
`different expert testimony and supporting evidence. These differences will be
`substantial, but Petitioner’s diligence makes it difficult, if not impossible, to fairly
`evaluate the amount of overlap at this early date. Patent Owner—who raised this
`issue and thus has the burden of proof—must demonstrate the amount of overlap,
`but it cannot do so by speculation. Fintiv at 5 (“When the patent owner raises an
`argument for discretionary denial under NHK….”); Zonar Sys. v. Innovative
`Global Sys., IPR2020-00154, Paper 16 at 12-13 (May 12, 2020) (declining to
`speculate regarding overlap). It would be contrary to Fintiv’s direction to consider
`“fairness” as part of a “holistic” analysis (Fintiv at 5-6) to penalize an
`exceptionally diligent petitioner for filing so early that the parties can only
`speculate regarding the relevant facts. Comcast Cable Commc’ns v. Veveo,
`IPR2019-00239, Paper 15 at 14 (July 5, 2019) (finding “insufficient persuasive
`evidence of overlap” even later in the ITC proceeding).
`Petitioners’ exceptional diligence also ensures there will be the minimum
`
`5
`
`
`
`IPR2020-00919 (USP 9,901,123)
`
`
`
`Petitioner’s Reply to POPR
`
`possible investment in the ITC case (Fintiv factor 3), favoring institution. In
`Samsung, for example, the Board found this factor was neutral even though claim
`construction was complete, fact and expert discovery including expert depositions
`were complete, and summary determination motions were filed five months before
`the Board’s institution decision. See Samsung at 12-13. In contrast, the relevant
`investment at institution will be much less here: summary determination motions
`are not due until afterwards, and any investment in claim construction is irrelevant
`because no claim terms from the ’123 patent are at issue in the ITC. Ex. 2029 at 1-
`2; Ex. 1038.
`The strong merits and other relevant circumstances also favor institution.
`(Fintiv factor 6). Regarding the merits, the challenged claims are invalid under all
`three grounds, two of which Patent Owner barely disputes. Petitioner disagrees
`with all of Patent Owner’s arguments, but in view of the procedural posture,
`Petitioner makes only a single legal point: Patent Owner misstates the law when it
`insists that evidence, such as Exs. 1015, 1016, and 1020, must be prior-art printed
`publications. POPR 33-41; Yeda, 906 F.3d at 1041-42 (“[T]he Board can rely on
`evidence other than just prior art,” for example, as “evidence of motivation.”).
`In addition, other circumstances weigh against a discretionary denial. This is
`not a case where the petitioner will merely pay damages if it fails to prove
`invalidity by clear and convincing evidence and is found to infringe. The remedy
`for infringement at the ITC is an injunction that would deprive the public of a less
`harmful alternative to conventional cigarettes. “Following a rigorous science-based
`review,” the FDA “determined that authorizing [the accused IQOS product] for the
`
`6
`
`
`
`IPR2020-00919 (USP 9,901,123)
`
`
`
`Petitioner’s Reply to POPR
`
`U.S. market is appropriate for the protection of public health.” Ex. 1053; Ex. 1052
`(FDA finding that IQOS “significantly reduces the body’s exposure” to harmful
`chemicals). Indeed, IQOS is the only heat-not-burn or vaping device cleared by the
`FDA since the controlling statute was enacted over ten years ago, and public-
`interest groups have also expressed concern that removing IQOS from the U.S.
`market will be deleterious to public health. Ex. 1040 at 002; Exs. 1041-1051.
`The other Fintiv factors do not outweigh these positives. As usual, the
`Board’s final written decision is due after ITC’s scheduled target date (despite
`Petitioner’s exceptional diligence), but long before the district court will lift the
`stay and decide validity (Fintiv factor 2). Apple Inc. v. Seven Networks, IPR2020-
`00506, Paper 11 at 9 n.6 (Sept. 1, 2020) (“holistically” weighing “factor 2 on a
`sliding scale” relative to the one-year bar) (“Seven”); Fintiv at 9 (factor 2
`addresses “the court’s trial date,” not a generic parallel proceeding or ITC); 28
`U.S.C. § 1659 (stay remains in place until ITC decision is final). The parties are
`the same (Fintiv factor 5), but this is usually the case and is therefore “neutral or
`weighing at most slightly in favor of denial.” Juniper Networks v. Packet
`Intelligence, IPR2020-00338, Paper 22 at 17 (Sept. 9, 2020); Seven at 15-16. And
`as demonstrated at the outset, the Board consistently institutes review despite an
`ongoing ITC case, even when the petitioner was far less diligent than the current
`case. Patent Owner has pointed to nothing that warrants departing from the Board’s
`well-established practice, including § 325(d), which was discussed above.
`
`7
`
`
`
`IPR2020-00919 (USP 9,901,123)
`
`
`
`Petitioner’s Reply to POPR
`
`
`
`
`
`
`
`Dated: September 18, 2020
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Respectfully submitted,
`
`By: / Jonathan M. Strang /
`
`Jonathan M. Strang (Reg. No. 61,724)
`jonathan.strang@lw.com
`Matthew J. Moore (Reg. No. 42,012)
`matthew.moore@lw.com
`Inge A. Osman (Reg. No. 74,480)
`inge.osman@lw.com
`Latham & Watkins LLP
`555 Eleventh Street, NW, Ste. 1000
`Washington, D.C. 20004-1304
`Telephone: 202.637.2200
`Fax: 202.637.2201
`
`Christopher W. Henry (Reg. No. 60,907)
`christopher.henry@lw.com
`Latham & Watkins LLP
`200 Clarendon Street
`Boston, MA 02116
`Telephone: 617.948,6000
`Fax: 617.948.6001
`
`
`
`
`Counsel for Petitioner
`Philip Morris Products, S.A.
`
`
`
`8
`
`
`
`IPR2020-00919 (USP 9,901,123)
`
`
`
`Petitioner’s Reply to POPR
`
`
`
`
`
`
`
`CERTIFICATE OF SERVICE
`
`
`
`Pursuant to 37 C.F.R. § 42.6(e), I certify that on this 18th day of September,
`
`2020, a true and correct copy of the foregoing Petitioner’s Reply to the Patent
`
`Owner Preliminary Response and all Exhibits were served by electronic mail on
`
`Patent Owner’s lead and backup counsel at the following email addresses:
`
`
`
`
`
`
`David M. Maiorana (Reg. No. 41,449)
`Kenneth S. Luchesi (Reg. No. 58,673)
`Jones Day
`901 Lakeside Avenue
`Cleveland, OH 44114
`Tel: 216.586.3939
`Fax: 216.579.0212
`dmaiorana@jonesday.com
`kluchesi@jonesday.com
`
`Anthony M. Insogna (Reg. No. 35,203)
`Jones Day
`4655 Executive Drive, Suite 1500
`San Diego, CA 92121-3134
`Tel: 858.314.1200
`Fax: 844.345.3178
`aminsogna@jonesday.com
`
`Geoffrey K. Gavin (Reg. No. 47,591)
`Jones Day
`1420 Peachtree Street, N.E., Suite 800
`Atlanta, GA 30309-3053
`Tel: 404.521.3939
`Fax: 404.581.8330
`ggavin@jonesday.com
`
`Joshua R. Nightingale (Reg. No. 67,865)
`Jones Day
`500 Grant Street, Suite 4500
`
`
`
`
`
`IPR2020-00919 (USP 9,901,123)
`
`
`
`Petitioner’s Reply to POPR
`
`By: / Jonathan M. Strang /
`
`Jonathan M. Strang (Reg. No. 61,724)
`jonathan.strang@lw.com
`Latham & Watkins LLP
`555 Eleventh Street, NW, Ste. 1000
`Washington, D.C. 20004-1304
`Telephone: 202.637.2200
`Fax: 202.637.2201
`
`Counsel for Petitioner
`Philip Morris Products, S.A.
`
`Pittsburgh, PA 15219-2514
`Tel: 412.391.3939
`Fax: 412.394.7959
`Email: jrnightingale@jonesday.com
`
`
`George N. Phillips (Reg. No. 68,001)
`Jones Day
`250 Vesey Street
`New York, NY 10281-1047
`Tel: 212.326.3939
`Fax: 212.755.7306
`Email: gphillips@jonesday.com
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`